Gesamtverzeichnis
-
1
Impact of rebate contract legislation on generic substitution of valproate – a retrospective study of ambulatory drug dispensing in the DAPI database
17. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie (GAA), 25.-26.11.2010, Osnabrück, Germany.
www.egms.de/static/de/meetings/gaa2010/10gaa08.shtml
Conflicts of interest: The DAPI received financial support for this study from Desitin; Kuhn K. employee Desitin.
-
1
Effect of generic switch on pharmacy refill compliance after ramipril patent expiry – a retrospective study using the DAPI database
17. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie (GAA), 25.-26.11.2010, Osnabrück, Germany.
www.egms.de/static/de/meetings/gaa2010/10gaa36.shtml
Conflicts of interest: none declared.
-
1
Incidence of thyroid hormone therapy in patients treated with sorafenib or sunitinib
26th ICPE - International Conference on Pharmacoepidemiology and Therapeutic Risk Assessment, 19.-22. August 2010, Brighton, England, UK: Pharmacoepi and Drug Safety 2010 Vol. 19 Suppl. 1 p. S 259 (Abstract number 611).
Conflicts of interest: RQ, AF, SF, KS, MS: This investigation of the DAPI - German Institute for Drug use Evaluation has been financially supported by Sanofi-Aventis Deutschland GmbH, Berlin, in the years 2008 and 2009. RQ: Results of this study have been presented at the 12th Annual European ISPOR-Congress in Paris (October 24 - 27, 2009), the 16th annual meeting of the Gesellschaft für Arzneimittelepidemiologie (GAA) e. V. in Berlin (November 19 - 20, 2009), and the 70th scientific sessions of the American Diabetes Association in Orlando (June 25 - 29, 2010). Registration fees and travel costs have been paid by Sanofi-Aventis Deutschland GmbH. MU, KL, WEM: None. FWD: Employee of Sanovi-Aventis Deutschland GmbH, Berlin.
-
1
Epidemiologische Analyse der Compliance
Symposium der Fachgruppe klinische Pharmazie (gemeinsam mit der Fachgruppe Industriepharmazie und der ESCP): "Compliance: Therapietreue in Wissenschaft und Praxis" auf der Jahrestagung der DPhG 2007 am 12. Oktober 2007, Erlangen, Germany.
Schuessel, Schulz (DAPI): Compliance Abstract DPhG Erlangen 2007
www.klinische-pharmazie.org/veranst/index.htm
Conflicts of interest: none declared.
-
1
Impact of risk communications and market withdrawals on prescribing of cyclooxygenase-2 inhibitors and non-selective nonsteroidal anti-inflammatory drugs
15. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie, 20.-21.11.2008, Bonn, Germany.
Czeche et al (DAPI) Abstract GAA 2008
Conflicts of interest: none declared.
-
1
Hypothyreosen unter Sorafenib- oder Sunitinib-Therapie
Studienkonzept Multikinasehemmer Hypothyreosen DAPI final
Conflicts of interest: none declared.
-
1
Apotheker Zielpreismodell (Update Mai 2010)
Apotheker Zielpreismodell - ein Garantiepreismodell mit Arzneimittelvielfalt. Deutscher Apothekerverband in Kooperation mit dem DAPI und ABDATA.
Conflicts of interest: none declared.
-
1
Persistence with basal supported oral therapy - comparison of insulin glargine versus NPH insulin.
ISPOR 12th Annual European Congress, 24.-27.10.2009, Paris, France
Value Health [abstract]. 2009; 12: A234 (DB2)
www.ispor.org/research_study_digest/research_index.asp
Conflicts of interest: The DAPI received financial support for this study from Sanofi-Aventis; Dippel F.W. employee Sanofi-Aventis.
-
1
Persistence with basal supported oral therapy - comparison of insulin glargine versus NPH insulin.
16. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie, 19.-20.11.2009, Berlin, Germany
Düsseldorf: German Medical Science GMS Publishing House; 2009.
Doc09gaa02. DOI: 10.3205/09gaa02, URN: urn:nbn:de:0183-09gaa021www.egms.de/en/meetings/gaa2009/09gaa02.shtml
Conflicts of interest: The DAPI received financial support for this study from Sanofi-Aventis; Dippel F.W. employee Sanofi-Aventis.
-
1
Pharmacy refill adherence with antidepressants.
DPhG Jahrestagung, 28.9.-1.10.2009, Jena, Germany
Hengstler DPhG 2009 - Pharmacy refill adherence with antidepressants
Conflicts of interest: none declared.